Featured Research

from universities, journals, and other organizations

Researchers aim for consensus on measuring the impact of visual impairment

Date:
April 1, 2010
Source:
Association for Research in Vision and Ophthalmology
Summary:
New guidelines that outline best practices for measuring the economic burden of visual impairment will make it easier for the policy, science and medical communities to draw conclusions and compare results across studies.

New guidelines that outline best practices for measuring the economic burden of visual impairment will make it easier for the policy, science and medical communities to draw conclusions and compare results across studies.

Related Articles


The guidelines arose from a working group convened by the Association for Research in Vision and Ophthalmology (ARVO) and the International Agency for the Prevention of Blindness (IAPB). They were published this month in the ARVO journal Investigative Ophthalmology and Visual Science.

The group, representing participants from around the world and from major vision research organizations, came together to review the methods used in two US studies and one Australian study and to develop a consensus on appropriate methods to employ in future studies on the cost of vision impairment regardless of where they are conducted.

"When estimates of the cost of visual impairment vary over time or across countries," explains Johns Hopkins University researcher Kevin Frick, PhD, the lead author, "policy makers are left to ponder whether one estimate differs from another because of changes in the population, changes in the impact of the disease or changes in the methods. Researchers can help policy makers by removing one of the potential variables -- changes in methods."

In September 2007 ARVO and IAPB organized the Vancouver Economic Burden of Vision Loss Group to examine the various methods used to measure visual impairment impact and recommend best practices. The panel of 12 leading vision researchers and health care professionals proposed seven guidelines, summarized as follows:

  1. A comprehensive list of costs includes monetary expenditures on health care (hospital, outpatient, and other), monetary expenditures on things other than health care, loss of patient productivity, loss of family member productivity, deadweight losses and loss of patient wellbeing.
  2. In any assessment of either prevalent or incident costs, the authors should identify the specific items included under the major categories in recommendation 1.
  3. Costs should be presented as separate line items to facilitate comparisons among studies.
  4. A default position is to use a single discount rate for all calculations in an analysis.
  5. The assumed value of purchasing a DALY or QALY should be clearly stated and justified.
  6. It is essential to indicate the perspective of costs included.
  7. The decision-making context and starting point of the analysis should be clear. A statement of whether and how the analysis will be used as part of other analyses is essential.

According to co-author Steven Kymes, PhD, of Washington University in St. Louis, "Higher quality studies using a methodology that consistently follows guidelines will help decision makers and advocates in the ophthalmology community to better understand the magnitude of the impact of visual impairment, how it is likely to change with demographic changes and no additional interventions, and how additional interventions can change the impact over time."

Dr. Frick says the next task is ensuring that the guidelines are disseminated within the research community. Hosting a workshop at an industry conference and sharing the recommendations in additional ophthalmology journals would enhance awareness of the guidelines and support efforts to adopt their practice.

"Following consensus-based guidelines will also make it easier for those asking questions about the impact of visual impairment to know that they are receiving high quality estimates," says Dr. Frick. "And those who are involved in the process of making sure only high quality proposals are funded and only high quality manuscripts get published will have an easier task."


Story Source:

The above story is based on materials provided by Association for Research in Vision and Ophthalmology. Note: Materials may be edited for content and length.


Journal Reference:

  1. K. D. Frick, S. M. Kymes, P. P. Lee, D. B. Matchar, M. L. Pezzullo, D. B. Rein, H. R. Taylor. The Cost of Visual Impairment: Purposes, Perspectives, and Guidance. Investigative Ophthalmology & Visual Science, 2010; 51 (4): 1801 DOI: 10.1167/iovs.09-4469

Cite This Page:

Association for Research in Vision and Ophthalmology. "Researchers aim for consensus on measuring the impact of visual impairment." ScienceDaily. ScienceDaily, 1 April 2010. <www.sciencedaily.com/releases/2010/04/100401164620.htm>.
Association for Research in Vision and Ophthalmology. (2010, April 1). Researchers aim for consensus on measuring the impact of visual impairment. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2010/04/100401164620.htm
Association for Research in Vision and Ophthalmology. "Researchers aim for consensus on measuring the impact of visual impairment." ScienceDaily. www.sciencedaily.com/releases/2010/04/100401164620.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins